Form D · Pharmaceuticals
JAZZ PHARMACEUTICALS INC
Palo Alto, CA · CIK 0001232524
Offering snapshot reported Nov 27, 2009 · SEC filing
- Reported sold
- $0 Offering amount: $2.02M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 7, 2008 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 27, 2009 | Amendment | $0 | No comparison | 1 | SEC filing |
| Nov 27, 2009 | Amendment | $80,000,000 | No comparison | 12 | SEC filing |
| Nov 25, 2009 | Amendment | $120,000,000 | No comparison | 12 | SEC filing |
| Jul 8, 2009 | Initial | $6,999,998 | No comparison | 2 | SEC filing |
| May 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 26, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 19, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-55145
Item 13(a) represents the aggregate exercise price of the Warrant. The original exercise price of the Warrant was $11.20 per share. On November 20, 2009, the Warrant was amended to reduce the exercise price of the Warrant to $9.20 per share.
Source: Form D, filed Nov 27, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| E. Alexander Albert | Director |
| Samuel D. Colella | Director |
| Joan E. Colligan | Executive |
| Bruce C. Cozadd | Director, Executive |
| Bruce Cozzad | Director, Executive |
| Brian C. Cressey | Director |
| Bryan C. Cressey | Director |
| Patrick G. Enright | Director |
| Carol A. Gamble | Executive |
| Michael W. Michaelson | Director |
| Michael W. Michelson | Director |
| James C. Momtazee | Director |
| Robert M. Myers | Director, Executive |
| Kenneth W. O'keefe | Director |
| Alan M. Sebulsky | Director |
| James B. Tananbaum | Director |
| Janne L.T. Wissel | Executive |
| Nathaniel M. Zilkha | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3180 Porter Drive
Palo Alto, CA, 94304
Palo Alto, CA, 94304